Quest Diagnost…
ProfileJobs (1.88 k)

Quest Diagnostics

Suggest Edit
    • Healthcareclinical researchclinicsmedical diagnostics

    Quest Diagnostics is the world's leading provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The Company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its extensive medical and scientific staff, cancer diagnostics, and anatomic pathology services.

    Quest Diagnostics's wide range of products and services benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies, and employers.

    Revenue(FY, 2017)
    $7.7 B
    Market capitalization(2018-09-21)
    $14.7 B
    TypePublic
    HQMadison, US
    Founded1967
    Size (employees)45,000 (est)+5%
    Websitequestdiagnostics.com
    Quest Diagnostics was founded in 1967 and is headquartered in Madison, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Quest Diagnostics

    Stephen H. Rusckowski

    Stephen H. Rusckowski

    Chairman, President and Chief Executive Officer

    Quest Diagnostics Office Locations

    Quest Diagnostics has offices in Barceloneta, Bayamón, Guaynabo, San Juan and in 6 other locations
    Madison, US (HQ)
    Giralda Farms
    Secaucus, US
    500 Plaza Dr
    Barceloneta, PR
    PR-2
    Bayamón, PR
    Av. Main
    Caguas, PR
    5 Av. Luis Muñoz Marín
    Caguas, PR
    5 Calle Padial
    Show all (12)
    Report incorrect company information

    Quest Diagnostics Financials and Metrics

    Quest Diagnostics Revenue

    Embed Graph
    Quest Diagnostics's revenue was reported to be $7.71 b in FY, 2017 which is a 2.6% increase from the previous period.
    USD

    Revenue (Q2, 2018)

    		3.8 b

    Gross profit (Q2, 2018)

    		1.3 b

    Gross profit margin (Q2, 2018), %

    		35.1%

    Net income (Q2, 2018)

    		422 m

    EBIT (Q2, 2018)

    		577 m

    Market capitalization (21-Sep-2018)

    		14.7 b

    Closing stock price (21-Sep-2018)

    		107.6

    Cash (30-Jun-2018)

    		132 m

    EV

    		18.3 b
    Quest Diagnostics's current market capitalization is $14.7 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		7.1 b7.4 b7.5 b7.5 b7.7 b

    Revenue growth, %

    		4%1%0%3%

    Cost of goods sold

    		4.3 b4.6 b4.7 b4.6 b4.7 b

    Gross profit

    		2.8 b2.8 b2.8 b2.9 b3 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Revenue

    		1.8 b1.7 b1.9 b1.9 b1.8 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b3.8 b

    Cost of goods sold

    		1.1 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b2.5 b

    Gross profit

    		698.6 m645 m728 m726 m676 m743 m718 m719 m751 m728 m734 m773 m741 m658 m1.3 b

    Gross profit Margin, %

    		39%37%38%38%37%39%38%39%39%39%39%40%38%35%35%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		187 m192 m133 m359 m137 m

    Accounts Receivable

    		926 m924 m

    Prepaid Expenses

    		155 m150 m

    Inventories

    		91 m110 m84 m82 m95 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Cash

    		158.3 m144 m144 m170 m974 m150 m123 m128 m283 m406 m367 m314 m350 m124 m132 m

    Inventories

    		85.2 m99 m109 m111 m106 m109 m86 m82 m80 m82 m77 m83 m100 m94 m91 m

    Current Assets

    		1.4 b1.5 b1.5 b1.6 b2.4 b1.5 b1.6 b1.5 b1.5 b1.6 b1.6 b1.5 b1.5 b1.4 b1.4 b

    PP&E

    		749.4 m851 m884 m888 m902 m906 m886 m925 m937 m952 m1 b1 b1.1 b1.2 b1.2 b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		883 m592 m753 m696 m824 m

    Depreciation and Amortization

    		304 m249 m270 m

    Accounts Payable

    		(21 m)68 m(24 m)56 m(8 m)

    Cash From Operating Activities

    		652 m938 m821 m1.1 b1.2 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Net Income

    		732.1 m111 m253 m392 m70 m199 m553 m114 m324 m529 m175 m382 m557 m189 m422 m

    Depreciation and Amortization

    		211 m75 m156 m235 m78 m153 m230 m62 m123 m186 m62 m128 m197 m74 m151 m

    Accounts Payable

    		(76.8 m)(86 m)(39 m)20 m(120 m)(49 m)(41 m)(77 m)23 m43 m(95 m)(93 m)(3 m)(68 m)(64 m)

    Cash From Operating Activities

    		441.6 m84 m364 m635 m52 m327 m539 m143 m464 m765 m196 m490 m852 m180 m503 m
    show all
    USDY, 2018

    EV/EBIT

    		31.7 x

    EV/CFO

    		36.4 x

    EV/FCF

    		52 x

    Debt/Equity

    		0.7 x

    Debt/Assets

    		0.3 x

    Financial Leverage

    		2 x
    Show all financial metrics

    Quest Diagnostics Operating Metrics

    FY, 2016

    Accounts

    		250 k

    Patents Issued

    		700

    Patents Pending

    		570

    Patient Service Centers

    		2.20 k
    Show all operating metrics

    Quest Diagnostics Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    California Laboratory AssociatesOctober 30, 2017
    Cleveland HeartLabOctober 18, 2017
    Cape Cod Healthcare - BusinessJune 28, 2017
    ClearPoint DiagnosticJune 12, 2017
    Med fusionJune 12, 2017
    PeaceHealth LaboratoriesFebruary 15, 2017

    Quest Diagnostics Revenue Breakdown

    Embed Graph

    Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other

    Report incorrect company information

    Competitors

    Thermo Fisher Scientific
    Healthcare - Public
    Laboratory Corporation of America Holdings
    Healthcare - Public
    Ixico
    Healthcare - Public
    New York-Presbyterian Hospital
    Education - Private
    Compare competitors

    Quest Diagnostics Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Quest Diagnostics News and Updates

    September 25, 2018

    Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec

    SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Sept. 25, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today...
    September 24, 2018

    Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics

    SECAUCUS, N.J. and WOBURN, Mass., Sept. 24, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services. About 10 percent of...
    September 19, 2018

    Revenue Cycle Management (RCM) Beating Market by Excellent Revenue growth by 2025 | Athenahealth, Cerner Corporation,Eclinicalworks, Mckesson, Quest Diagnostics

    Scope of the Report:This report studies the Revenue Cycle Management (RCM) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Revenue Cycle Management (RCM) …
    September 06, 2018

    Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent

    SECAUCUS, N.J., Sept. 6, 2018 /PRNewswire/ -- More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other drugs and dangerous drug combinations, finds a new...
    August 29, 2018

    Cognitive Assessment and Training in Healthcare Market In-Depth Analysis including key players Cambridge Cognition Ltd.(UK), Bracket(US), Quest Diagnostics

    HTF MI released a new market study on Global Cognitive Assessment and Training in Healthcare Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday
    August 17, 2018

    Quest Diagnostics Declares Quarterly Cash Dividend

    SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of...
    Show more
    Report incorrect company information

    Quest Diagnostics Company Life and Culture

    Report incorrect company information
    Download PDF